Egyptian Liver Journal

Table 2 Mean values of baseline levels for both HCV RNA (IU/ml) and HCVcAg (Peiu/ml) assays among the studied groups

From: Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Studied groups	Baseline levels
	HCV RNA serum level (IU/ml)	Kruskal-Wallis test P value	Post hoc test	HCVcAg serum level (Peiu/ml)	ANOVA test and P value	Post hoc test
	Mean ± SD	Kruskal-Wallis test P value	Post hoc test	Mean ± SD	ANOVA test and P value	Post hoc test
Group I (n = 140)	95648.1 ± 50814.0	Test = 22.76 P < 0.001**	P1 < 0.001 P2 = 0.001 P3 = 0.002*	1.4 ± 0.35	Test = 69.69 P < 0.001**	P1 = 0.002* P2 < 0.001 P3 < 0.001
Group II (n = 80)	1082313.0 ± 558186.7			2.6 ± 0.68
Group III (n = 60)	4812067.8 ± 1837006.9			5.9 ± 1.5

*Significant
**Highly significant

Back to article page